ArticleTargeted oncology2019

Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).

Heike Liewen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.